Wells Fargo’s Greenwich LifeSciences GLSI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Buy |
3,150
+239
| +8% | +$2.17K | ﹤0.01% | 5253 |
|
|
2025
Q1 | $27.8K | Buy |
2,911
+64
| +2% | +$611 | ﹤0.01% | 5149 |
|
|
2024
Q4 | $32K | Buy |
2,847
+1,008
| +55% | +$11.3K | ﹤0.01% | 5130 |
|
|
2024
Q3 | $26.4K | Sell |
1,839
-72
| -4% | -$1.04K | ﹤0.01% | 5157 |
|
|
2024
Q2 | $33K | Buy |
1,911
+1,870
| +4,561% | +$32.3K | ﹤0.01% | 5067 |
|
|
2024
Q1 | $818 | Hold |
41
| – | – | ﹤0.01% | 5797 |
|
|
2023
Q4 | $431 | Buy |
41
+3
| +8% | +$32 | ﹤0.01% | 5975 |
|
|
2023
Q3 | $336 | Buy |
38
+13
| +52% | +$115 | ﹤0.01% | 6072 |
|
|
2023
Q2 | $241 | Buy |
25
+1
| +4% | +$10 | ﹤0.01% | 6338 |
|
|
2023
Q1 | $331 | Hold |
24
| – | – | ﹤0.01% | 6314 |
|
|
2022
Q4 | $365 | Buy |
24
+1
| +4% | +$15 | ﹤0.01% | 6145 |
|
|
2022
Q3 | $0 | Sell |
23
-4
| -15% | – | ﹤0.01% | 6570 |
|
|
2022
Q2 | $0 | Sell |
27
-894
| -97% | – | ﹤0.01% | 6739 |
|
|
2022
Q1 | $18K | Sell |
921
-1,425
| -61% | -$27.9K | ﹤0.01% | 5706 |
|
|
2021
Q4 | $57K | Buy |
2,346
+2,221
| +1,777% | +$54K | ﹤0.01% | 5463 |
|
|
2021
Q3 | $5K | Hold |
125
| – | – | ﹤0.01% | 6036 |
|
|
2021
Q2 | $6K | Sell |
125
-1,009
| -89% | -$48.4K | ﹤0.01% | 5943 |
|
|
2021
Q1 | $38K | Hold |
1,134
| – | – | ﹤0.01% | 5579 |
|
|
2020
Q4 | $41K | Buy |
+1,134
| New | +$41K | ﹤0.01% | 5445 |
|